New Delhi, Oct 9 (IANS) India will become a global leader in biopharmaceuticals, bio-manufacturing, and life sciences by 2030, said Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, on Wednesday.
Singh said this while speaking at the sixth CII Pharma and Life Sciences Summit: 2024, held in the national capital on Wednesday.
He commended the country for “emerging as a hub for affordable and high-quality medicines”. India must now also focus on vaccine equity, and technology transfer to boost global vaccination efforts, Singh said.
“The ‘Make in India’ initiative is playing a pivotal role in reducing our dependence on imported Active Pharmaceutical Ingredients (APIs). By strengthening our domestic manufacturing, we are not only bolstering self-reliance but also ensuring critical healthcare supplies are readily available,” the Minister said.
“We now rank third in pharmaceutical production by volume and 14th by value,” he added.
Lauding the pharma industry, Singh said the transition from a generic-focused model to the development of biopharmaceuticals and biosimilars, has been one of the “most remarkable shifts”.
Further, the Minister said the next industrial revolution will come from the biotech sector.
“Thanks to initiatives like the PLI scheme, India is well on its way to becoming a global leader in biopharmaceuticals, bio-manufacturing, and life sciences by 2030,” he said, adding “There is still much to be achieved”.
The development of the world’s first DNA vaccine for COVID-19 and the efforts to develop the first human papillomavirus (HPV) vaccine for adolescent girls, which will prevent cervical cancer exemplified India’s leadership in global health.
India has also significantly transformed health outcomes, especially for low- and middle-income countries, by producing 65 per cent of the world’s vaccines.
–IANS
rvt/uk
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
